Using nicotine replacement therapy could help some smokers quit gradually

Apr 03, 2009

Smokers who do not want to quit right now, but are prepared to try to reduce their smoking are twice as likely to stop smoking in the long-term if they use nicotine replacement therapy (NRT) to help them cut down gradually, according to research published on bmj.com today.

The research is the first of its kind to focus on sustained abstinence using NRT for smokers who have no immediate plans to stop smoking.

Smoking is one of the greatest causes of illness and premature death in the world. Half of UK smokers try to stop every year but only 2-3% of them succeed. One of the reasons for this is that while the majority of smokers want to quit, only a minority feel ready to do so abruptly. These smokers, say the authors, might have more success by following assisted reduction to stop (NARS) programmes, also known as 'cut down then stop, 'cut down to stop' and 'cut down to quit.'

The research team at the University of Birmingham, carried out a systematic review of seven randomised controlled trials that compared the outcomes of using NRT gum or inhalators to placebos.

The trials enrolled almost 3000 smokers who were given NRT for 6-18 months, 6.75% of NRT smokers achieved six months of sustained abstinence - twice the proportion who were given placebos. This amounts to 3% of smokers quitting who otherwise would not have done so. The authors note that "previous data suggest that half of those who sustain six months of abstinence will maintain it for the rest of their lives." Using the therapy while smoking does not lead to serious health problems.

The authors make it clear that most of the evidence comes from trials with regular behavioural support and monitoring, and it is unclear whether using NRT without this regular contact would be as effective.

This study is important because "it shows that treating a population of smokers not ready to stop means more of them stop." The authors conclude that it is therefore important to consider how NARS can be incorporated into existing tobacco control programmes.

Source: British Medical Journal (news : web)

Explore further: A novel therapy for sepsis?

add to favorites email to friend print save as pdf

Related Stories

Not ready to quit? Try cutting back

Dec 07, 2006

In a review article in the December Nicotine and Tobacco Research, researchers at the University of Vermont have found an unexpected, effective alternative to motivate smokers to quit smoking – cutting back. According to ...

Smoking cessation therapies more effective than placebos

Jul 14, 2008

Six treatments for smoking cessation perform better than placebos — including varenicline (Chantix®), recently approved for use in Canada — states a team of researchers from McGill University and the University of Montreal ...

Recommended for you

A novel therapy for sepsis?

9 hours ago

A University of Tokyo research group has discovered that pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering ...

Cellular protein may be key to longevity

Sep 15, 2014

Researchers have found that levels of a regulatory protein called ATF4, and the corresponding levels of the molecules whose expression it controls, are elevated in the livers of mice exposed to multiple interventions ...

Gut bacteria tire out T cells

Sep 15, 2014

Leaky intestines may cripple bacteria-fighting immune cells in patients with a rare hereditary disease, according to a study by researchers in Lausanne, Switzerland. The study, published in The Journal of Experimental Me ...

User comments : 0